Company Presentation • 19 Nov 2025 09:00
Company Presentation • 13 Nov 2025 14:00
Company Presentation • 06 Nov 2025 14:30
Company Presentation • 14 Aug 2025 14:30
Company Presentation • 12 May 2025 14:30
Search or
𝛼SK
𝛼SKENTITY
Pharmaessentia Corp (6446 TT)
Pharmaessentia Corp (6446 TT)
83
Analysis
Health Care • Taiwan
PharmaEssentia Corporation develops and distributes therapeutic products for treatment in human disease. The Company develops drugs to treat hepatitis, chronic myeloid leukemia (CML), essential thrombocythemia (ET), myeloid fibrosis (MF), polycythemia vera (PV), hepatitis and cancer.
morex